FR13C0049I1 - - Google Patents

Info

Publication number
FR13C0049I1
FR13C0049I1 FR13C0049C FR13C0049I1 FR 13C0049 I1 FR13C0049 I1 FR 13C0049I1 FR 13C0049 C FR13C0049 C FR 13C0049C FR 13C0049 I1 FR13C0049 I1 FR 13C0049I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR13C0049(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR13C0049I1 publication Critical patent/FR13C0049I1/fr
Application granted granted Critical
Publication of FR13C0049I2 publication Critical patent/FR13C0049I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR13C0049C 1995-09-05 2013-08-13 Nouvelles 1-ar(alk)yl-imidazolin-2-ones a effet anticonvulsif contenant un reste amine bisubstitue en position 4 et procede permettant de les preparer Active FR13C0049I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
PCT/EP1996/003295 WO1997009314A1 (de) 1995-09-05 1996-07-26 Neue, antikonvulsiv wirkende 1-ar(alk)yl-imidazolin-2-one, die in 4-stellung einen disubstituierten amin-rest enthalten, und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
FR13C0049I1 true FR13C0049I1 (zh) 2013-09-27
FR13C0049I2 FR13C0049I2 (fr) 2014-03-28

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
FR13C0049C Active FR13C0049I2 (fr) 1995-09-05 2013-08-13 Nouvelles 1-ar(alk)yl-imidazolin-2-ones a effet anticonvulsif contenant un reste amine bisubstitue en position 4 et procede permettant de les preparer

Country Status (32)

Country Link
EP (1) EP0863880B1 (zh)
JP (1) JP4030578B2 (zh)
CN (1) CN1103762C (zh)
AR (1) AR003502A1 (zh)
AT (1) ATE254606T1 (zh)
AU (1) AU700602B2 (zh)
BG (1) BG63917B1 (zh)
BR (1) BR9610359A (zh)
CA (1) CA2184871C (zh)
CZ (1) CZ291839B6 (zh)
DE (2) DE19532668A1 (zh)
DK (1) DK0863880T3 (zh)
EA (1) EA000535B1 (zh)
EE (1) EE03562B1 (zh)
ES (1) ES2208758T3 (zh)
FR (1) FR13C0049I2 (zh)
GE (1) GEP20022652B (zh)
HK (1) HK1015776A1 (zh)
HU (1) HU225956B1 (zh)
IL (1) IL123333A (zh)
LT (1) LT4482B (zh)
LU (1) LU92263I2 (zh)
NO (1) NO313829B1 (zh)
NZ (1) NZ315624A (zh)
PL (1) PL188287B1 (zh)
PT (1) PT863880E (zh)
SK (1) SK284868B6 (zh)
TR (1) TR199800476T1 (zh)
TW (1) TW422838B (zh)
UA (1) UA46790C2 (zh)
WO (1) WO1997009314A1 (zh)
ZA (1) ZA967014B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
MXPA05013196A (es) * 2003-07-11 2006-03-09 Elbion Ag Metodo para tratar o evitar trastornos del sistema nervioso central con compuestos que tienen selectividad por la subunidad alfa 3 del receptor de benzodiazepina.
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
JP2014521714A (ja) 2011-08-12 2014-08-28 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング ネコ科動物の心不全を治療および予防する方法において使用するための奇異性電流（Ｉｆ）阻害薬
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
NO980906D0 (no) 1998-03-02
ZA967014B (en) 1997-08-18
EA000535B1 (ru) 1999-10-28
HK1015776A1 (en) 1999-10-22
CN1103762C (zh) 2003-03-26
CA2184871A1 (en) 1997-03-06
CA2184871C (en) 2001-08-21
TR199800476T1 (xx) 1998-06-22
JPH11512101A (ja) 1999-10-19
NO313829B1 (no) 2002-12-09
CN1200728A (zh) 1998-12-02
DE59610827D1 (de) 2003-12-24
DE19532668A1 (de) 1997-03-06
SK284868B6 (sk) 2006-01-05
EE03562B1 (et) 2001-12-17
PL188287B1 (pl) 2005-01-31
HUP9802941A2 (hu) 1999-09-28
ES2208758T3 (es) 2004-06-16
BR9610359A (pt) 1999-07-06
LT98047A (en) 1998-10-26
NZ315624A (en) 1998-11-25
ATE254606T1 (de) 2003-12-15
IL123333A (en) 2001-10-31
CZ291839B6 (cs) 2003-06-18
PL325413A1 (en) 1998-07-20
SK21698A3 (en) 1998-10-07
BG63917B1 (bg) 2003-06-30
GEP20022652B (en) 2002-03-25
PT863880E (pt) 2004-04-30
DK0863880T3 (da) 2004-03-22
BG102287A (en) 1998-09-30
AU700602B2 (en) 1999-01-07
LU92263I2 (fr) 2013-10-07
LT4482B (lt) 1999-03-25
AU6737596A (en) 1997-03-27
TW422838B (en) 2001-02-21
HU225956B1 (en) 2008-01-28
JP4030578B2 (ja) 2008-01-09
EA199800271A1 (ru) 1998-10-29
NO980906L (no) 1998-03-02
EP0863880A1 (de) 1998-09-16
EP0863880B1 (de) 2003-11-19
FR13C0049I2 (fr) 2014-03-28
EE9800063A (et) 1998-08-17
IL123333A0 (en) 1998-09-24
WO1997009314A1 (de) 1997-03-13
CZ66198A3 (cs) 1998-07-15
UA46790C2 (uk) 2002-06-17
HUP9802941A3 (en) 1999-10-28
AR003502A1 (es) 1998-08-05
MX9801742A (es) 1998-08-30

Similar Documents

Publication Publication Date Title
DE69638352D1 (zh)
DE69637714D1 (zh)
BR122012014331A2 (zh)
IN184245B (zh)
IN188196B (zh)
BRPI9612258B1 (zh)
BRPI9612138B1 (zh)
DK143195A (zh)
ECSDI950232S (zh)
FR13C0049I1 (zh)
FR2730101B1 (zh)
CH0741373H1 (zh)
DK0727898T3 (zh)
IN184770B (zh)
IN186165B (zh)
IN188365B (zh)
BR7501503U (zh)
IN179400B (zh)
IN178287B (zh)
IN183732B (zh)
BR7502120U (zh)
ECSDI950233S (zh)
DK126096A (zh)
IN185632B (zh)
IN181709B (zh)